ABSTRACT
BACKGROUND: Cardiac arrhythmias are sometimes encountered in patients with hereditary myopathies and muscular dystrophies. Description of arrhythmias in myopathies and muscular dystrophies is very important, because arrhythmias have a strong impact on the outcomes for these patients and are potentially treatable. CASE PRESENTATION: A girl with severe congenital RYR1-related myopathy exhibited atrial tachycardia and sinus node dysfunction during infancy. She was born after uncomplicated caesarian delivery. She showed no breathing, complete ophthalmoplegia, complete bulbar paralysis, complete facial muscle paralysis, and extreme floppiness. At 5 months old, she developed persistent tachycardia around 200-210 beats per minutes. Holter monitoring revealed ectopic atrial tachycardia during tachyarrhythmia and occasional sinus pauses with junctional escape beats. Propranolol effectively alleviated tachyarrhythmia but was discontinued due to increased frequency and duration of the sinus pauses that led to bradyarrhythmia. There was no evidence of structural heart diseases or heart failure. The arrhythmia gradually resolved spontaneously and at 11 months old, she showed complete sinus rhythm. CONCLUSIONS: Although supraventricular arrhythmia is sometimes encountered in congenital myopathies, this is the first report of cardiac arrhythmia requiring drug intervention in RYR1-associated myopathy.
Subject(s)
Genetic Predisposition to Disease , Myopathies, Structural, Congenital/genetics , Ryanodine Receptor Calcium Release Channel/genetics , Sick Sinus Syndrome/genetics , Tachycardia, Ectopic Atrial/genetics , Tachycardia, Supraventricular/genetics , Electrocardiography/methods , Electrocardiography, Ambulatory/methods , Female , Follow-Up Studies , Humans , Infant , Myopathies, Structural, Congenital/complications , Myopathies, Structural, Congenital/diagnosis , Propranolol/therapeutic use , Risk Assessment , Severity of Illness Index , Sick Sinus Syndrome/complications , Sick Sinus Syndrome/physiopathology , Tachycardia, Ectopic Atrial/complications , Tachycardia, Ectopic Atrial/diagnosis , Tachycardia, Ectopic Atrial/drug therapy , Tachycardia, Supraventricular/complications , Tachycardia, Supraventricular/physiopathology , Treatment OutcomeABSTRACT
Multifocal atrial tachycardia (MAT) has a well-known association with Costello syndrome, but is rarely described with related RAS/MAPK pathway disorders (RASopathies). We report 11 patients with RASopathies (Costello, Noonan, and Noonan syndrome with multiple lentigines [formerly LEOPARD syndrome]) and nonreentrant atrial tachycardias (MAT and ectopic atrial tachycardia) demonstrating overlap in cardiac arrhythmia phenotype. Similar overlap is seen in RASopathies with respect to skeletal, musculoskeletal and cutaneous abnormalities, dysmorphic facial features, and neurodevelopmental deficits. Nonreentrant atrial tachycardias may cause cardiac compromise if sinus rhythm is not restored expeditiously. Typical first-line supraventricular tachycardia anti-arrhythmics (propranolol and digoxin) were generally not effective in restoring or maintaining sinus rhythm in this cohort, while flecainide or amiodarone alone or in concert with propranolol were effective anti-arrhythmic agents for acute and chronic use. Atrial tachycardia resolved in all patients. However, a 4-month-old boy from the cohort was found asystolic (with concurrent cellulitis) and a second patient underwent cardiac transplant for heart failure complicated by recalcitrant atrial arrhythmia. While propranolol alone frequently failed to convert or maintain sinus rhythm, fleccainide or amiodarone, occasionally in combination with propranolol, was effective for RASopathy patient treatment for nonreentrant atrial arrhythmia. Our analysis shows that RASopathy patients may have nonreentrant atrial tachycardia with and without associated cardiac hypertrophy. While nonreentrant arrhythmia has been traditionally associated with Costello syndrome, this work provides an expanded view of RASopathy cardiac arrhythmia phenotype as we demonstrate mutant proteins throughout this signaling pathway can also give rise to ectopic and/or MAT.
Subject(s)
Cardiomyopathy, Hypertrophic/genetics , Costello Syndrome/genetics , Noonan Syndrome/genetics , Tachycardia, Ectopic Atrial/genetics , ras Proteins/genetics , Amiodarone/therapeutic use , Arrhythmias, Cardiac/drug therapy , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/physiopathology , Calcium/metabolism , Cardiomyopathy, Hypertrophic/drug therapy , Cardiomyopathy, Hypertrophic/physiopathology , Costello Syndrome/drug therapy , Costello Syndrome/physiopathology , Digoxin/therapeutic use , Female , Humans , Infant , Infant, Newborn , LEOPARD Syndrome/genetics , LEOPARD Syndrome/physiopathology , Male , Noonan Syndrome/drug therapy , Noonan Syndrome/physiopathology , Propranolol/therapeutic use , Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics , Proto-Oncogene Proteins c-raf/genetics , Proto-Oncogene Proteins p21(ras)/genetics , SOS1 Protein/genetics , Tachycardia, Ectopic Atrial/drug therapy , Tachycardia, Ectopic Atrial/physiopathology , ras Proteins/classificationABSTRACT
No disponible
Subject(s)
Adult , Humans , Male , Sinus Arrest, Cardiac/genetics , /methods , Tachycardia, Ectopic Atrial/genetics , ElectrocardiographyABSTRACT
Atrial fibrillation (AF) is associated with structural remodeling in atrial myocytes. Emerging evidence suggests that statin has a protective effect on AF through cholesterol-independent mechanisms. The aim of this study is to investigate whether heme oxygenase-1 (HO-1), a potent antioxidant system, mediates the suppressive effect of statin on atrial tachycardia-induced structural remodeling. Treatment of cultured atrium-derived myocytes (HL-1 cell line) with rosuvastatin enhanced HO-1 expression/activity and attenuated tachypacing-induced oxidative stress and myofibril degradation. Heme oxygenase-1 inhibitors and small-interfering RNA for HO-1 blocked the inhibitory effect of rosuvastatin on tachypacing-stimulated changes, suggesting the crucial role of HO-1 in mediating the effect of rosuvastatin. Time-dependent experiments and loss-of-function study demonstrated that Akt/Nrf2 pathways lay to the up-stream of HO-1 in this signaling cascade. Furthermore, the involvement of Akt/Nrf2/HO-1 pathway in the antioxidant effect of rosuvastatin was documented in an ex vivo tachypacing model. The suppressive effect of statin on atrial tachypacing-induced cellular remodeling is mediated via the activation of Akt/Nrf2/HO-1 signaling, which provides a possible explanation for the protective effect of statin on AF.
Subject(s)
Heme Oxygenase-1/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Myocytes, Cardiac/metabolism , NF-E2-Related Factor 2/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rosuvastatin Calcium/pharmacology , Signal Transduction/drug effects , Tachycardia, Ectopic Atrial/metabolism , Animals , Atrial Remodeling/drug effects , Collagen/metabolism , Disease Models, Animal , Enzyme Activation , Fibroblasts/metabolism , Gene Expression , Heme Oxygenase-1/genetics , Male , Oxidative Stress/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Rats , Tachycardia, Ectopic Atrial/genetics , Tachycardia, Ectopic Atrial/pathologyABSTRACT
Locus mapping has uncovered diverse etiologies for familial atrial fibrillation (AF), dilated cardiomyopathy (DCM), and mixed cardiac phenotype syndromes, yet the molecular basis for these disorders remains idiopathic in most cases. Whole-exome sequencing (WES) provides a powerful new tool for familial disease gene discovery. Here, synergistic application of these genomic strategies identified the pathogenic mutation in a familial syndrome of atrial tachyarrhythmia, conduction system disease (CSD), and DCM vulnerability. Seven members of a three-generation family exhibited the variably expressed phenotype, three of whom manifested CSD and clinically significant arrhythmia in childhood. Genome-wide linkage analysis mapped two equally plausible loci to chromosomes 1p3 and 13q12. Variants from WES of two affected cousins were filtered for rare, predicted-deleterious, positional variants, revealing an unreported heterozygous missense mutation disrupting the highly conserved kinase domain in TNNI3K. The G526D substitution in troponin I interacting kinase, with the most deleterious SIFT and Polyphen2 scores possible, resulted in abnormal peptide aggregation in vitro and in silico docking models predicted altered yet energetically favorable wild-type mutant dimerization. Ventricular tissue from a mutation carrier displayed histopathological hallmarks of DCM and reduced TNNI3K protein staining with unique amorphous nuclear and sarcoplasmic inclusions. In conclusion, mutation of TNNI3K, encoding a heart-specific kinase previously shown to modulate cardiac conduction and myocardial function in mice, underlies a familial syndrome of electrical and myopathic heart disease. The identified substitution causes a TNNI3K aggregation defect and protein deficiency, implicating a dominant-negative loss of function disease mechanism.
Subject(s)
Arrhythmias, Cardiac/genetics , Cardiomyopathy, Dilated/genetics , Genetic Association Studies , Heart Conduction System/abnormalities , MAP Kinase Kinase Kinases/genetics , Mutation , Tachycardia, Ectopic Atrial/genetics , Adult , Amino Acid Sequence , Arrhythmias, Cardiac/diagnosis , Brugada Syndrome , Cardiac Conduction System Disease , Cardiomyopathy, Dilated/diagnosis , Cardiomyopathy, Dilated/metabolism , Child , Chromosome Mapping , Chromosomes, Human, Pair 1 , Conserved Sequence , Exome , Female , Genetic Loci , Genetic Variation , Haplotypes , High-Throughput Nucleotide Sequencing , Humans , MAP Kinase Kinase Kinases/chemistry , MAP Kinase Kinase Kinases/metabolism , Male , Middle Aged , Models, Molecular , Molecular Sequence Data , Myocardium/metabolism , Myocardium/pathology , Myocardium/ultrastructure , Organic Chemicals , Pedigree , Protein Conformation , Protein Interaction Domains and Motifs , Protein Serine-Threonine Kinases , Sequence Alignment , Syndrome , Tachycardia, Ectopic Atrial/diagnosisSubject(s)
Atrial Fibrillation/genetics , Atrial Flutter/genetics , DNA/genetics , Mutation , Ryanodine Receptor Calcium Release Channel/genetics , Tachycardia, Ectopic Atrial/genetics , Atrial Fibrillation/metabolism , Atrial Fibrillation/physiopathology , Atrial Flutter/complications , Atrial Flutter/metabolism , Child, Preschool , DNA Mutational Analysis , Electrocardiography , Female , Follow-Up Studies , Humans , Ryanodine Receptor Calcium Release Channel/metabolism , Tachycardia, Ectopic Atrial/complications , Tachycardia, Ectopic Atrial/metabolismABSTRACT
We report a family with a previously not described hereditary form of ectopic atrial tachycardia. The tachycardia had an autosomal dominant mode of inheritance, was not associated with structural heart disease and had a benign course.
Subject(s)
Tachycardia, Ectopic Atrial/genetics , Adolescent , Electrocardiography , Female , Genes, Dominant , Humans , PedigreeABSTRACT
UNLABELLED: Atrial APD and Polymorphic AT in LQTS. INTRODUCTION: Prolongation of the QT interval and torsades de pointes tachycardias due to altered expression or function of repolarizing ion channels are the hallmark of congenital long QT syndrome (LQTS). The same ion channels also contribute to atrial repolarization, and familial atrial fibrillation may be associated with a mutated KVLQT1 gene. We therefore assessed atrial action potential characteristics and atrial arrhythmias in LQTS patients. METHODS AND RESULTS: Monophasic action potentials (MAPs) were simultaneously recorded from the right atrial appendage and the inferolateral right atrium in 10 patients with LQTS (8 with identifiable genotype) and compared to 7 control patients. Atrial arrhythmias also were compared to MAPs recorded in patients with persistent (n = 10) and induced (n = 4) atrial fibrillation. Atrial action potential durations (APD) and effective refractory periods (ERP) were prolonged in LQTS patients at cycle lengths of 300 to 500 msec (APD prolongation 30-41 msec; ERP prolongation 26-52 msec; all P < 0.05). Short episodes of polymorphic atrial tachyarrhythmias (polyAT, duration 4-175 sec) occurred spontaneously or during pauses after pacing in 5 of 10 LQTS patients, but not in controls (P < 0.05). P waves showed undulating axis during polyAT. Cycle lengths of polyAT were longer than during persistent and induced atrial fibrillation. Afterdepolarizations preceded polyAT in 2 patients. The electrical restitution curve was shifted to longer APD in LQTS patients and to even longer APD in LQTS patients with polyAT. CONCLUSION: This group of LQTS patients has altered atrial electrophysiology: action potentials are prolonged, and polyAT occurs. PolyAT appears to be a specific arrhythmia of LQTS reminiscent of an atrial form of "torsades de pointes".
Subject(s)
Action Potentials , Atrial Fibrillation/diagnosis , Atrial Fibrillation/physiopathology , Electrocardiography , Heart Atria/physiopathology , Heart Conduction System/physiopathology , Long QT Syndrome/diagnosis , Long QT Syndrome/physiopathology , Adolescent , Adult , Atrial Fibrillation/genetics , Female , Heart Atria/innervation , Humans , Long QT Syndrome/genetics , Male , Middle Aged , Polymorphism, Genetic , Tachycardia, Ectopic Atrial/diagnosis , Tachycardia, Ectopic Atrial/genetics , Tachycardia, Ectopic Atrial/physiopathologySubject(s)
Action Potentials , Atrial Fibrillation/diagnosis , Atrial Fibrillation/physiopathology , Electrocardiography , Heart Atria/physiopathology , Heart Conduction System/physiopathology , Long QT Syndrome/diagnosis , Long QT Syndrome/physiopathology , Adolescent , Adult , Atrial Fibrillation/genetics , Female , Heart Atria/innervation , Humans , Long QT Syndrome/genetics , Male , Middle Aged , Polymorphism, Genetic , Tachycardia, Ectopic Atrial/diagnosis , Tachycardia, Ectopic Atrial/genetics , Tachycardia, Ectopic Atrial/physiopathologyABSTRACT
BACKGROUND: Atrial fibrillation causes electrophysiological changes of the atrium, thereby facilitating its maintenance. Although the expression of ion channels is modulated in chronic atrial fibrillation, it is yet unknown whether paroxysmal atrial fibrillation can also lead to electrical remodeling by affecting gene expression. METHODS AND RESULTS: To examine the short-term effects of rapid pacing on the mRNA level of voltage-dependent K(+) channels, high-rate atrial pacing was performed in Sprague-Dawley rat hearts. Total RNA was prepared from the atrial appendages from 0 to 8 hours after the onset of pacing, and mRNA levels of Kv1.2, Kv1. 4, Kv1.5, Kv2.1, Kv4.2, Kv4.3, erg, KvLQT1, and minK were determined by RNase protection assay. Among these 9 genes, the mRNA level of the Kv1.5 channel immediately and transiently increased, with bimodal peaks at 0.5 and 2 hours after the onset of pacing. Conversely, the pacing gradually and progressively decreased the mRNA levels of the Kv4.2 and Kv4.3 channels. The increase of Kv1.5 and the decrease of Kv4.2 and Kv4.3 mRNA levels were both rate dependent. In correspondence with the changes in the mRNA level, Kv1. 5 channel protein transiently increased in the membrane fraction of the atrium during a 2- to 8-hour pacing period. Electrophysiological findings that the shortening of the action potential produced by 4-hour pacing was almost abolished by a low concentration of 4-aminopyridine implied that the increased Kv1.5 protein was functioning. CONCLUSIONS: Even short-term high-rate atrial excitation could differentially alter the mRNA levels of Kv1.5, Kv4.2, and Kv4.3 in a rate-dependent manner. In particular, increased Kv1.5 gene expression, having a transient nature, implied the possible biochemical electrical remodeling unique to paroxysmal tachycardia.
Subject(s)
Atrial Function/genetics , Myocardium/metabolism , Pacemaker, Artificial , Potassium Channels, Voltage-Gated , Potassium Channels/genetics , Tachycardia, Ectopic Atrial/physiopathology , Action Potentials/physiology , Acute Disease , Animals , Antisense Elements (Genetics) , Atrial Fibrillation/genetics , Atrial Fibrillation/physiopathology , Blotting, Western , Chronic Disease , DNA Primers , Delayed Rectifier Potassium Channels , ERG1 Potassium Channel , Electrophysiology , Ether-A-Go-Go Potassium Channels , Gene Expression/physiology , Heart Atria/chemistry , Heart Atria/metabolism , Heart Conduction System/physiology , Heart Rate/physiology , KCNQ Potassium Channels , KCNQ1 Potassium Channel , Kv1.2 Potassium Channel , Kv1.4 Potassium Channel , Kv1.5 Potassium Channel , Myocardium/chemistry , Potassium Channels/analysis , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Shab Potassium Channels , Shal Potassium Channels , Tachycardia, Ectopic Atrial/geneticsABSTRACT
Hypoplastic left heart syndrome (HLHS) is the most common cause of death from heart disease in the first week of life. There are reports about familial concordance by presumed morphogenetic mechanisms of abnormal embryonic blood flow with phenotypes of varying severity. The risk of having a child with a left heart lesion after a previously affected child may be as high as 5% to 12%. We present case reports from four families in which sustained fetal arrhythmia (three ectopic atrial tachycardias and one severe bradycardia due to excessive ectopic atrial beats) was demonstrated. Within these four families a close relative of the mother (a previous child, a brother, or a nephew) had severe left heart abnormality (three with HLHS and one with severe aortic valve stenosis). The association of sustained fetal arrhythmia of ectopic atrial origin and severe left heart abnormalities could be expected to occur by chance in a very low percentage of cases. We conclude that sustained fetal atrial ectopic arrhythmia is a congenital abnormality and should be considered as a risk factor for inherited congenital heart abnormalities.